Clinical focus expansion IHP's core emphasis on laboratory services, toxicology, hormone, tissue and genetic testing, plus potential to operate an ambulatory surgical center, suggests an opportunity to cross-sell value-added lab services, screening programs, and ASC partnerships to physician networks seeking integrated care and revenue diversification.

Regulatory monitoring opportunity With rising government focus on prescription drug misuse and a proven need for monitoring and compliance, position IHP as a partner to healthcare systems and physician practices for implementing robust toxicology screening, patient monitoring programs, and diversion prevention.

Data-driven services Leverage IHP's experience in drug testing data and population health insights to offer analytics dashboards, patient risk stratification, and performance reporting to practices and payors aiming to improve adherence, optimize opioid stewardship, and demonstrate value-based outcomes.

SMB partner potential With a lean team size and revenue in the lower mid-market range, target mid-sized clinics, independent practices, and regional hospital networks seeking turnkey revenue opportunities, streamlined operations, and scalable laboratory/ASC solutions.

Tech-enabled outreach IHP's existing tech stack and online presence indicate opportunities to deploy digital marketing collaborations, telehealth-enabled screening programs, and secure patient data flows to attract new physician partners and expand distribution channels.